The efficacy of first-line tyrosine kinase inhibitors combined with co-medications in Asian patients with EGFR mutation non-small cell lung cancer

por Su, Vincent Yi-Fong, Yang, Kuang-Yao, Huang, Ting-Yu, Hsu, Chia-Chen, Chen, Yuh-Min, Yen, Jiin-Cherng, Chou, Yueh-Ching, Chang, Yuh-Lih, He, Chien-Hui
Publicado 2020